• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 9808560
Device Problems Fracture (1260); Material Separation (1562); Deformation Due to Compressive Stress (2889); Naturally Worn (2988)
Patient Problem Discomfort (2330)
Event Date 01/04/2022
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was not provided, a review of the device history records could not be performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
 
Event Description
It was reported that eleven months post port implant via the right subclavian vein, the patient allegedly experienced discomfort and upon x-ray fluoroscopy a few millimeters of the catheter was noted to be fractured.The distal catheter segment and the port body was reportedly removed using radiological procedures.The current status of the patient is unknown.
 
Manufacturer Narrative
As the lot number for the device was not provided, a review of the device history records could not be performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
 
Event Description
It was reported that eleven months post port implant via the right subclavian vein, the patient allegedly experienced discomfort and upon x-ray fluoroscopy a few millimeters of the catheter was noted to be fractured.The distal catheter segment and the port body was reportedly removed using radiological procedures.The current status of the patient is unknown.
 
Event Description
It was reported that one year ten months post port implant via the right subclavian vein, the patient allegedly experienced discomfort.It was further reported that the x-ray revealed the device allegedly had a break.Reportedly, the distal catheter segment and the port body was removed using radiological procedures.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported is unknown.Investigation summary: one powerport mri isp implantable port attached to a groshong catheter in two segments were returned for evaluation.Gross visual, microscopic evaluation and functional testing were performed.The investigation is confirmed for the reported catheter fracture, material separation and identified deformation and wear issues a complete circumferential break was noted approximately 0.1cm from the distal end of the cath-lock and appeared elliptical in shape.The distal catheter segment was returned and measured approximately 16.8cm in length.A complete circumferential break was noted to the proximal end of the distal catheter segment and appeared elliptical in shape.A circumferential split was noted approximately 0.7 cm from proximal end of the distal catheter segment.The edges of the complete circumferential break on both proximal and distal end appeared to be jagged; the surface of the break appeared to be round in one region and granular in the other region, glossy throughout.During functional evaluation, leak was noted from the circumferential split on the distal catheter segment upon infusion.The identified break is typical of flexural fatigue, which is due to the repetitive, cyclic kinking of the catheter.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
judy ludwig
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key13410675
MDR Text Key285924576
Report Number3006260740-2022-00121
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027512
UDI-Public(01)00801741027512
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9808560
Device Catalogue Number9808560
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/25/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/05/2022
Initial Date FDA Received02/01/2022
Supplement Dates Manufacturer Received02/08/2022
Supplement Dates FDA Received02/14/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-